The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Cytori Therapeutics Inc (CYTX)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
An Expanded Emerging Stem Cell Index

Feb 04, 2009 03:07 AM GMT
Mikerun
Return Risk
+1.04% MID
Principal

An Expanded Emerging Stem Cell Index
 
By Mike Havrilla on 2/3/09
ETF Innovators
 
The table at my website link below includes 32 companies in the ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks with market caps below $250M. I will maintain the index with these 32 components and track the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and regenerative medicine space.
 
 
Below is a list of all 32 companies in descending order by market cap with a total value of $1.27B and an average stock price change of -15% over the past year for the index, as compared to losses of 20% for the Healthcare Sector SPDR (XLV), 4.7% for SPDR S&P Biotech (XBI), 9.1% for iShares Nasdaq Biotech (IBB), and 18.9% for PowerShares Biotech & Genome (PBE).
 
StemCells (STEM)
BioMimetic Therapeutics (BMTI)
 
RTI Biologics (RTIX) – announced an $11.75M financing ($10M credit facility + $1.75M term loan) on Monday to replace its previous line of credit and supplement the Company's working capital needs.
 
Cytori Therapeutics (CYTX) – commenced patient enrollment last week in an investigator-initiated 10-patient study using adipose-derived stem cells processed by Cytori's Celution 800 System to treat stress urinary incontinence.
 
Aastrom Biosciences (ASTM)
Mesoblast (MBLTY)
 
BioTime (BTIM) – biggest stock gain in past year (up over 700%)
 
Osteotech (OSTE)
Neuralstem (CUR)
RegeneRx Biopharma (RGN)
 
ThermoGenesis (KOOL) – will report its fiscal 2Q09 results tomorrow with a conference call after the market close at 5 pm (ET).
 
Athersys (ATHX)
Advanced Cell Technology (ACTC)
International Stem Cell Corp (ISCO)
 
Bioheart (BHRT) – up over 20% today on news of a grant-funded study in Italy for the Bioheart A&C Bio Science Twin-Pulsatile Life Support System which is expected to be completed within just 45 days with the potential for $2.1M in contract sales if results are positive.
 
Pluristem Therapeutics (PSTI)
HepaLife Technologies (HPLF)
Stem Cell Innovations   (SCLL)
Isolagen (ILE)
CellCyte Genetics Corp (CCYG)
Cryo-Cell (CCEL)
Stem Cell Therapeutics (SCTPF)
Brainstorm Cell Therapeutics (BCLI)
Stem Cell Authority (SCAL)
Opexa Therapeutics (OPXA)
Neostem (NBS)
Bio-Matrix Scientific Group (BMSN)
Cord Blood America (CBAI)
MediStem (MEDS)
Stem Cell Therapy Internt'l (SCII)
MultiCell Technologies (MCET)
LifeStem International (LSTM)


CYTX:  This call was made on 02/04/09 @ $4.24
Rating:   Positive   $4.24 (02/04/09)
Closed:   02/09/2009 @ $4.23 (-0.24% in 5 days)


Comments (1)

Add Comment

Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 414 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Cytori Therapeutics Inc (CYTX)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
83.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
AMRN Positive +86.01% 11/29/10
IBB Positive +39.69% 11/22/10
EXAS Positive +35.19% 10/21/10
BIOD Positive -83.37% 10/17/10
LCI N/A Positive -21.73% 10/06/10

View All >
   
Mike Havrilla previously rated CYTX
Positive -54.94% Extreme FDA, Clinical Trial Trades: Stocks Under $5
04/11/2010
9
Positive +1.53% Single Digit FDA, Clinical Trial Stocks: $GNVC, $ACUR, $CADX, $CYTX
03/27/2010
9
Positive -29.17% Cytori (NASDAQ: CYTX): FDA 510(k) Celution Clearance, Heart Data Pending
01/08/2010
9
Positive +0.47% Cytori’s (NASDAQ: CYTX) Natural Celution for Breast Reconstruction
12/12/2009
9
Positive +5.05% BioMed Updates: Dec 6-8
12/08/2009
9
Positive +65.05% BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI
11/16/2009
9
Positive -0.53% BioMed News Bytes: Cytori (NASDAQ: CYTX), Questcor (NASDAQ: QCOR)
10/16/2009
9
Positive +7.47% FDA Calendar Extreme Trades: 85 Single Digit Stocks
10/13/2009
9
Positive -4.92% BioMed News Bytes: Cytori, EXACT Sciences, HEPI
10/03/2009
9
Positive -8.04% Cytori’s Cardiac Celution: Encouraging Interim Data (NASDAQ: CYTX)
09/23/2009
9
Positive +5.29% The Latest Story on Cytori (NASDAQ:CYTX)
09/14/2009
9
Positive +51.20% Stem Cell Index Surges in Past Week
05/10/2009
9
Positive +38.12% BioMedReports.com Most Popular Links
04/09/2009
9
Positive -7.65% Cytori Therapeutics: Stock Profile and 2009 Outlook
03/14/2009
9
Positive -6.67% Stem Cell Index Soars on Lift of Funding Ban
03/10/2009
9
Positive -7.89% Analysis of Global Stem Cell Index YTD
03/04/2009
9
Positive -17.39% Cytori Therapeutics: A Natural Play on Cosmetic Medicine
03/01/2009
9
Positive -12.66% Global Stem Cell and Regenerative Medicine Index
02/25/2009
10
Positive -2.17% Global Stem Cell Index Down 9% Last Week
02/22/2009
9
Positive -21.22% Global Stem Cell and Regenerative Medicine Index
02/18/2009
9
Positive +4.06% Stem Cell Index Down 7% in Past Week
02/16/2009
9
Positive -6.86% Stem Cell Index Down 1% in Past Week
02/09/2009
9
Positive -15.20% New Emerging Stem Cell Index
02/02/2009
9
Positive +35.87% Index to Track New Era for Stem Cell Cos.
01/23/2009
9
Positive +1.94% 20 Emerging Healthcare Stocks to Watch in '09
01/10/2009
9
Positive -6.48% Stem Cell & Regenerative Medicine Stocks Surge in Past Month
12/20/2008
9
Positive +33.10% Trading the Trials: Cytori and Cypress Bio
12/09/2008
9
Positive +34.88% Eyeing Opportunities in Micro-Cap Bio-Pharma Index
12/02/2008
9
Positive -18.87% Regenerative Medicine: The Next Frontier for Big Pharma
11/17/2008
9
Positive +1.15% Cytori Therapeutics: Set for a Sale to Olympus?
11/13/2008
9
Positive -7.42% Bullish on CYTX ...
11/12/2008
0
Positive -29.25% Cosmetic & Reconstructive Medicine: An Industry Profile
10/12/2008
9
Positive -23.81% Investors Flee Stocks for Gold and Safe Havens
09/30/2008
3
Positive -25.21% Cosmetic and Reconstructive Medicine (CRM): An Industry Profile
08/15/2008
3
Positive +6.04% Cytori Therapeutics (CYTX) Relieves Funding Concern & Announces 2Q08 Operating Results
08/08/2008
3
Positive -11.02% Cytori Therapeutics Enters Agreement for StemSource Cell Bank Sales in Singapore
08/04/2008
3
Positive +30.30% The Stem Cell Celution® for Success at Cytori Therapeutics
07/15/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch